ILOTYCIN
Live / Allowed — First extension granted (statement of use) (as of 20 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99569887
- Mark type
- Word mark
- Filed
- 29 Dec 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Antibiotic preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions
Owner
- Adventapharma DWC LLC, Dubai Marina, AE
- Adventapharma DWC LLC, Dubai Marina, AE
Prosecution history
- 21 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2026 — SOU EXTENSION 1 GRANTED
- 20 Aug 2026 — SOU EXTENSION 1 FILED
- 20 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Apr 2026 — PUBLISHED FOR OPPOSITION
- 08 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Mar 2026 — ASSIGNED TO EXAMINER
- 29 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Dec 2025 — NEW APPLICATION ENTERED
- 29 Dec 2025 — APPLICATION FILING RECEIPT MAILED